Skip to content

Effect of nagaradi kwath aschyotan in kaphaj abhishyanda(acute mucopurulent conjunctivitis)

Randomised controlled clinical trial to study the effect of nagaradi kwath aschyotan in kaphaj abhishyanda with special reference to acute mucopurulent conjunctivits - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072101
Enrollment
110
Registered
2024-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H100- Mucopurulent conjunctivitis

Interventions

None listed

Sponsors

Dr Chetan narayan gotad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.patients with classical signs and symptoms of kaphaj abhishyanda. 2. age group of 18 to 50 years. 3. patients willing to participate with consent

Exclusion criteria

Exclusion criteria: 1.patient below the age of 18 and above 50 yrs of age. 2. patient with Corneal ulcers,Kerato conjunctivitis Kraumatic occular injuries complicated Dacryocystitis Diabeties myelitis

Design outcomes

Primary

MeasureTime frame
Reduction in signs and symptoms of kaphaj abhishyand after application of nagaradi kwath aschyotan.Timepoint: 7 days

Secondary

MeasureTime frame
where the trial group stands in comparison with control group in reduction with signs and symptoms of kaphaj abhishyanda.Timepoint: 18 months

Countries

India

Contacts

Public ContactDr chetan narayan gotad

SMBT Ayurved College and Hospital

dr.tusharfirke@gmail.com9823388720

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026